S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
NYSE:USPH

U.S. Physical Therapy (USPH) Stock Price, News & Analysis

$110.90
+1.24 (+1.13%)
(As of 03/27/2024 ET)
Today's Range
$110.14
$111.84
50-Day Range
$92.27
$110.90
52-Week Range
$78.08
$124.11
Volume
43,749 shs
Average Volume
70,423 shs
Market Capitalization
$1.67 billion
P/E Ratio
82.15
Dividend Yield
1.59%
Price Target
$125.67

U.S. Physical Therapy MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
13.3% Upside
$125.67 Price Target
Short Interest
Healthy
4.95% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$1.14 M Sold Last Quarter
Proj. Earnings Growth
10.47%
From $2.77 to $3.06 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.33 out of 5 stars

Medical Sector

480th out of 939 stocks

Health Services Industry

4th out of 10 stocks

USPH stock logo

About U.S. Physical Therapy Stock (NYSE:USPH)

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.

USPH Stock Price History

USPH Stock News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
USPH Apr 2024 155.000 call
Q4 2023 US Physical Therapy Inc Earnings Call
U.S. Physical Therapy 2023 Earnings Preview
Best Online Respiratory Therapy Programs Of 2024
See More Headlines
Receive USPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Ex-Dividend for 4/5 Dividend
3/11/2024
Today
3/27/2024
Dividend Payable
4/05/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health services
Sub-Industry
Health Care Facilities
CUSIP
90337L10
Employees
6,720
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$125.67
High Stock Price Target
$138.00
Low Stock Price Target
$117.00
Potential Upside/Downside
+13.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$28.24 million
Pretax Margin
8.16%

Debt

Sales & Book Value

Annual Sales
$604.80 million
Cash Flow
$4.70 per share
Book Value
$31.85 per share

Miscellaneous

Free Float
14,797,000
Market Cap
$1.67 billion
Optionable
Optionable
Beta
1.38
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives


USPH Stock Analysis - Frequently Asked Questions

Should I buy or sell U.S. Physical Therapy stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" USPH shares.
View USPH analyst ratings
or view top-rated stocks.

What is U.S. Physical Therapy's stock price target for 2024?

4 brokers have issued twelve-month target prices for U.S. Physical Therapy's shares. Their USPH share price targets range from $117.00 to $138.00. On average, they predict the company's stock price to reach $125.67 in the next twelve months. This suggests a possible upside of 13.3% from the stock's current price.
View analysts price targets for USPH
or view top-rated stocks among Wall Street analysts.

How have USPH shares performed in 2024?

U.S. Physical Therapy's stock was trading at $93.14 at the start of the year. Since then, USPH stock has increased by 19.1% and is now trading at $110.90.
View the best growth stocks for 2024 here
.

When is U.S. Physical Therapy's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our USPH earnings forecast
.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) issued its quarterly earnings results on Wednesday, February, 28th. The company reported $0.59 earnings per share for the quarter, topping analysts' consensus estimates of $0.57 by $0.02. The business had revenue of $154.80 million for the quarter, compared to the consensus estimate of $150.24 million. U.S. Physical Therapy had a net margin of 4.67% and a trailing twelve-month return on equity of 8.52%. The firm's revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.58 earnings per share.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Tuesday, February 27th. Shareholders of record on Tuesday, March 12th will be given a dividend of $0.44 per share on Friday, April 5th. This represents a $1.76 dividend on an annualized basis and a yield of 1.59%. The ex-dividend date of this dividend is Monday, March 11th. This is an increase from the stock's previous quarterly dividend of $0.43.
Read our dividend analysis for USPH
.

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy (NYSE:USPH) pays an annual dividend of $1.76 per share and currently has a dividend yield of 1.61%. The company has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 130.37%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, USPH will have a dividend payout ratio of 57.52% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for USPH.

What ETFs hold U.S. Physical Therapy's stock?
What is Chris Reading's approval rating as U.S. Physical Therapy's CEO?

38 employees have rated U.S. Physical Therapy Chief Executive Officer Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among the company's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (7.09%), Vanguard Group Inc. (7.05%), Copeland Capital Management LLC (4.98%), Boston Trust Walden Corp (3.65%), Southernsun Asset Management LLC (3.20%) and Schroder Investment Management Group (2.85%). Insiders that own company stock include Anne Motsenbocker, Carey P Hendrickson, Christopher J Reading, Clayton Trier, Edward L Kuntz, Eric Joseph Williams, Glenn Mcdowell, Graham D Reeve, Graham D Reeve, Harry S Chapman, Harry S Chapman, Kathleen A Gilmartin, Mark J Brookner and Richard Binstein.
View institutional ownership trends
.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:USPH) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners